Friday, 4 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 3, 2025

Stocks Climb on Fed Rate Cut Optimism

View original at nasdaq.com
Stocks Climb on Fed Rate Cut Optimism The S&P 500 Index ($SPX) (SPY) on Wednesday closed up by +0.30%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up by +0.86%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up by +0.20%…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q3 net revenue of $1.36 billion

    80% confidence
  • Q4 revenue forecast of $251-252 million

    80% confidence
  • Q3 net revenue of $2.08 billion

    80% confidence
  • Q3 earnings rose 14.6%, more than doubling expectations of 7.2% y/y

    80% confidence
  • Upgraded Astera Labs to buy with price target of $275

    80% confidence
  • Q4 operating income forecast of $220-230 million

    80% confidence
  • Upgraded Stellantis to buy from neutral with price target of $12

    80% confidence
  • Full-year adjusted EPS forecast cut to $1.94-$2.04 from $2.35-$2.45

    80% confidence
  • 83% of reporting S&P 500 companies exceeded forecasts, on course for best quarter since 2021

    80% confidence
  • Microsoft is reducing its AI software sales quotas amid consumer resistance to newer products

    80% confidence
  • Will announce selection for new Fed Chair in early 2026

    80% confidence
  • Upgraded Vertex Pharmaceuticals to overweight from equal weight with price target of $516

    80% confidence
  • Quarterly cash dividend cut to $0.72 per share from $1.32 to preserve liquidity

    80% confidence
  • 2026 comparable sales growth forecast raised to low single digits from flat

    80% confidence
  • Q3 adjusted EPS forecast of 40 cents

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com
Stocks Climb on Fed Rate Cut Optimism — Source | Via News | ViaNews EU